Tag: New York
Reining in AI Use in Medicare Advantage: Biden Administration’s Plan
The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence, and ensuring access to behavioral health providers and additional benefits....
Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions
Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage
The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...
Optimistic Vaccine Activist: Embracing Hope for the Future
The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz, Jay Bhattacharya, and Joseph A. Ladapo, public health advocates are...
Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know
Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...
FAQs: Understanding IGAs in Animals
Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...
Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment
Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not only the gene therapy startup itself but also its drug...
Medicaid Official Criticizes Republican Reform as Poor Policy
Medicaid, a program that provides health coverage to millions of low-income Americans, is facing potential cuts as Republicans look to fund tax cuts and other priorities. The outgoing Medicaid chief under the Biden administration...
Apellis Triumphs while Astellas Faces Defeat
Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter.
Here's what you...
RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability
Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....
Dr. Oz appointed by Trump to head Medicare and Medicaid
President-elect Trump has chosen Dr. Mehmet Oz, a well-known surgeon and television personality, to lead the Centers for Medicare and Medicaid Services. This agency plays a crucial role in setting policies that affect payments...
Merck Drug Trial and Wegovy in China: Pharmalittle News Update
Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
